Atlas Trials

Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer

Clinical trial NCT02348450 · UNKNOWN

Trial details

NCT number
NCT02348450
Sponsor
Guangdong Association of Clinical Trials
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2015-02-01
Primary completion
2017-02-01
Enrollment
308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.